Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tritz DB, Doll DC, Ringenberg QS, Anderson S, Madsen R, Perry MC, et al. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer 1989;63:763–6. doi: 10.1002/1097-0142(19890215)63:4<763::AID-CNCR2820630426>3.0.CO;2-F .
Bezwoda WR, Lewis D, Livini N. Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications. Cancer 1986;58:1762–5. doi: 10.1002/1097-0142(19861015)58:8<1762::AID-CNCR2820580830>3.0.CO;2-V .
Trillet V, Revel D, Combaret V, Favrot M, Loire R, Tabib A, et al. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies. Br J Cancer 1989;60:83–8.
Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med 1999;40:1623–9.
Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kühn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999;17:2381–9.
Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–7. doi: 10.1056/NEJMoa022136 .
Donohoe KJ, Henkin RE, Royal HD, Brown ML, Collier BD, O’Mara RE, et al. Procedure guidelines for bone scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med 1996;37:1903–6.
Krasnow AZ, Hellman RS, Timins ME, Collier D, Anderson T, Isitman AT. Diagnostic bone scanning in oncology. Semin Nucl Med 1997;27:107–41. doi: 10.1016/S0001-2998(97)80043-8 .
Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999;23:123–9. doi: 10.1097/00004728-199901000-00026 .
Roland J, van den Weygaert D, Krug B, Brans B, Scalliet P, Vandevivere J. Metastases seen on SPECT imaging despite a normal planar bone scan. Clin Nucl Med 1995;20:1052–4. doi: 10.1097/00003072-199512000-00002 .
Sedonja I, Budihna NV. The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. Clin Nucl Med 1999;24:407–13. doi: 10.1097/00003072-199906000-00006 .
Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001;42:1800–4.
Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006;47:287–97.
Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998;16:3375–9.
Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998;25:1244–7. doi: 10.1007/s002590050291 .